Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Immunofluorescence Assay Market Size Changed, over the years?

There has been a robust growth in the size of the immunofluorescence assay market in the past few years. It is forecasted that this market will expand from $3.34 billion in 2024 to $3.59 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%. The growth in the previous period is credited to factors like enhanced disease diagnosis, a surge in research & development, an increase in autoimmune diseases, heightened cancer diagnostic endeavors, and an escalation in virology research.

How Much Will the Immunofluorescence Assay Market Be Worth in 2029?

The market size for immunofluorescence assays is projected to experience swift expansion in the coming years, reaching a value of $5.4 billion in 2029. The compound annual growth rate (CAGR) is anticipated to be 10.7%. The surge during the forecasted period can be credited to the rise in personalized medicines, increased monitoring of infectious diseases, growing autoimmune disorders, an upward trend in point-of-care testing, and enhanced readiness for global health issues. Prominent trends for the forecast period encompass assays multiplexing, automation and robotics, high-content imaging, state-of-the-art fluorophores, and the integration of digital pathology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6778&type=smp

Which is the Largest Company in the Immunofluorescence Assay Market?

Major companies operating in the immunofluorescence assay market include Thermo Fisher Scientific Inc., Abcam plc, Bio-Rad Laboratories Inc., PerkinElmer Inc., Werfen Company, Merck KGaA, Danaher Corporation, Cell Signaling Technology Inc., Vector Laboratories Inc., INOVA Diagnostics Inc., Sino Biological Inc., Medipan GmbH, BioLegend Inc., Jackson ImmunoResearch Laboratories Inc., Rockland Immunochemicals Inc., Bethyl Laboratories Inc., Fitzgerald Industries International Inc., Creative Diagnostics, Boster Biological Technology, Acris Antibodies GmbH, RayBiotech Inc., Proteintech Group Inc., Novus Biologicals LLC, R&D Systems Inc., OriGene Technologies Inc., GenScript Biotech Corporation, MBL International Corporation, Abnova Corporation, Cellabs India Technologies Limited, J. Mitra & Co. Pvt. Ltd., EpiGentek Group Inc., Elabscience Biotechnology Co. Ltd., Aesku.Diagnostics GmbH

What Are the Main Market Drivers in the Immunofluorescence Assay Industry?

The escalation in the occurrence of chronic illnesses is a significant contributor to the expansion of the immunofluorescence assay market. This is due in large part to evolving lifestyles, eating habits, and inadequate weight control, all of which are contributing to the fast-paced rise in chronic conditions. Some of these long-term chronic infections can even lead to cancer. Given the immunofluorescence assays’ extensive use in diagnosis and drug development, the spike in chronic disease prevalence is expected to stimulate their demand. For example, a study by the Centers for Disease Control and Prevention discloses that 6 in every 10 adults in the USA suffer from a chronic disease, which incurs around $3.8 trillion in yearly healthcare expenses. As such, the continuing increase in chronic disease occurrence should spur demand for immunofluorescence assays in the future.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6778&type=smp

How Is the Immunofluorescence Assay Market Segments Structured?

The immunofluorescence assay market covered in this report is segmented –

1) By Type: Direct Immunofluorescence, Indirect Immunofluorescence

2) By Product: Reagents, Instruments, Antibodies, Kits, Consumables and Accessories

3) By Disease: Cancer, Infectious Disease, Cardiovascular Diseases, Autoimmune Diseases, Other Diseases

4) By End User: Academic And Research Institutions, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Hospitals And Diagnostic Centers

Subsegments:

1) By Direct Immunofluorescence: Single-Step Direct Assays, Multiplex Direct Assays

2) By Indirect Immunofluorescence: Single-Step Indirect Assays, Multiplex Indirect Assays

What Strategic Trends Are Transforming the Immunofluorescence Assay Market?

The immunofluorescence assay market is seeing significant growth due to technological advancements. Companies in this field are diligently working on innovative product development to cater to specific technical needs, especially in the diagnosis of emerging viruses like COVID-19, and to establish a strong market presence. For example, LumiraDx, a UK-based point-of-care diagnostics firm, in March 2022, gained emergency approval for LumiraDx SARS-CoV-2 Ag Test. It’s a microfluidic immunofluorescence assay specifically crafted to detect the nucleocapsid protein antigen qualitatively from nasal swab samples.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

Which Global Regions Offer the Highest Growth in the Immunofluorescence Assay Market?

North America was the largest region in the immunofluorescence assay market in 2024, and it is also expected to be the fastest-growing region in the forecast period. The regions covered in the immunofluorescence assay market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6778

This Report Delivers Insight On:

1. How big is the immunofluorescence assay market, and how is it changing globally?

2. Who are the major companies in the immunofluorescence assay market, and how are they performing?

3. What are the key opportunities and risks in the immunofluorescence assay market right now?

4. Which products or customer segments are growing the most in the immunofluorescence assay market?

5. What factors are helping or slowing down the growth of the immunofluorescence assay market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model